Who we are
and the problems
we solve ...

Today’s skincare market is aiming to develop and provide efficient treatment solutions for more than 3 000 skin diseases. Driven by this challenge, combined with the high medical need, a multitude of new or improved formulas are under constant development and get released each year into a fast growing and highly diverse global Dermatology market.

Despite of the fact that there are tremendous international R&D activities in Biopharma, Cosmetics, and Medical industry there is an extreme lack of objective technologies for easy detecting, monitoring and analysis of the investigated skin issues and for validating safety and efficacy of the tested treatment options. The visual assessment of skin disorders is limited in precision and can be highly time-consuming, often leading to weak information and results, especially when the study size or observed effects are small.

In the end, inefficient procedures costs healthcare providers a lot of time and money and can lower also the change of a treatment success. Thus novel and state of the art digital solutions for global health care industry and patients are required.

Management Board

Harald Schnidar

PhD MBA
CEO, President & Founder

Stefan Schnidar

MSc
CTO

Kathrin Schnidar

BSc
CFO

Advisory Board

Richard Partl

Dr. med
Oncology & Clinical RnD

Christian Posch

MD, PhD
Board Certified Dermatologist

Hannes Trattner

Dr. med
Board Certified Dermatologist

Alexander Habinski

SaaS Expert

Our interdisciplinary team delivers state of the art digital solutions closing technology gaps in Dermatology and Telemedicine

The clinically validated software platform Scarletred® is on market since 2015 and enables high quality remote skin imaging and analysis in a multitude of skin conditions. Our first product and award winning technology is supplied internationally via flexible Software as a Service (SaaS) to Biopharma, Cosmetics and Medtech companies. The platform has been extended in 2020 by new Telemedicine SaaS tools for governmental, hospital and medical routine use.

SCARLETRED - Company history and milestones
01
2012-13

02
2014-15
03
2016-17
04
2018-2019
05
2020-2021
0
01
02
03
04
05
2012-2013
2014-2015
2016-2017
2018
2019

Clinical proof of concept

EUR 500K Pre-seed

SCARLETRED Holding GmbH in Vienna, Austria

Applications worldwide, granted in first health care markets

Go Silicon Valley at Plug&Play Tech Center (USA)

CE medical device class 1 for Scarletred®Vision

App of the Year Award by Futurezone

EUR 800K AWS Seed

1st in EU (Biopharma)

1st in USA (Medtech)

Global Nr 1 (Cosmetics)

Austrian State Prize "Digital Solution" by
Federal Ministry of Science, Research and Economy (BMWFW)

Crowd investment EUR 600K EUR (Greenrocket)

SCARLETRED Inc in Boston (USA)

Granted in Europe and USA

Boston Landing Zone at CIC (USA)

Young Innovators by WSA United Nations

Granted in Japan, Australia and other markets

ISO 13485 Quality Management System

Top of Styria Award

Tech Start-Up Award

We're part of